The IL-17 neutralizing antibody treatment reverses the inflammatory response mediated by Th17 cells and alveolar enlargement in an experimental model of chronic obstructive pulmonary disease (COPD)
Year: 2024
Type: conference-abstract
Institution: Universidade de São Paulo
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4404100842
